Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
NCT02032030 is an observational study sponsored by Washington University School of Medicine. As of 18 Nov 2026, it is completed. It studies Angina, Atrial Fibrillation and 14 more conditions. The registry lists an enrollment of 73,952 participants at 1 site in 1 country. The registry lists a start date of 31 Jul 2012 and a primary completion date of 31 Oct 2020.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02032030 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Washington University School of Medicine |
| Enrollment | 73,952 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Angina, Atrial Fibrillation, Cardiac Arrest, Congestive Heart Failure, Deep Vein Thrombosis, Delirium and 10 more conditions |
| Start | 31 Jul 2012 |
| Primary completion | 31 Oct 2020 |
| Study completion | 21 Oct 2020 |
| Last update posted | 9 Aug 2022 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Anshuman Sharma, MD
Washington University School of Medicine
Study Director - Arbi Ben Abdallah, PhD
Washington University School of Medicine
Study Director - Daniel Helsten, MD
Washington University School of Medicine
Study Director - Michael S Avidan, MBBCh, FCASA
Washington University School of Medicine
Principal Investigator - Troy Wildes, MD
Washington University School of Medicine
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barnes-Jewish Hospital
St Louis
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02032030
Each answer restates registry values shown on this page.
What is NCT02032030?
NCT02032030 is an observational study sponsored by Washington University School of Medicine. It studies Angina, Atrial Fibrillation and 14 more conditions.
Who leads NCT02032030?
The registry names Anshuman Sharma, MD (study director, Washington University School of Medicine), Arbi Ben Abdallah, PhD (study director, Washington University School of Medicine), Daniel Helsten, MD (study director, Washington University School of Medicine) and 2 more officials as overall officials.
Where does NCT02032030 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02032030 end?
The registry lists a primary completion date of 31 Oct 2020 and a study completion date of 21 Oct 2020. The sponsor last updated the record on 9 Aug 2022.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.